Global Reporting Initiative
Universal Standards
Choose a disclosure
General Disclosures / GRI 2-1
General Disclosures / GRI 2-2
General Disclosures / GRI 2-3
General Disclosures / GRI 2-4
General Disclosures / GRI 2-5
General Disclosures / GRI 2-6
General Disclosures / GRI 2-7
General Disclosures / GRI 2-8
General Disclosures / GRI 2-9
General Disclosures / GRI 2-10
General Disclosures / GRI 2-11
General Disclosures / GRI 2-12
General Disclosures / GRI 2-13
General Disclosures / GRI 2-14
General Disclosures / GRI 2-15
General Disclosures / GRI 2-16
General Disclosures / GRI 2-17
General Disclosures / GRI 2-18
General Disclosures / GRI 2-19
General Disclosures / GRI 2-20
General Disclosures / GRI 2-21
General Disclosures / GRI 2-22
General Disclosures / GRI 2-23
General Disclosures / GRI 2-24
General Disclosures / GRI 2-25
General Disclosures / GRI 2-26
General Disclosures / GRI 2-27
General Disclosures / GRI 2-28
General Disclosures / GRI 2-29
General Disclosures / GRI 2-30
Material Topics / GRI 3-1
Material Topics / GRI 3-2
Material Topics / GRI 3-3
General Disclosures
GRI 2-1
Organizational details
RD Saúde (RADL3) is a publicly traded company listed on the Novo Mercado, a special trading segment of the São Paulo Stock Exchange B3 (Brasil, Bolsa, Balcão) that includes only companies that can demonstrate that they adopt the most advanced corporate governance practices.
© 2024 RaiaDrogasil – Todos os direitos reservados. | Produzido por
Português
English